Exelixis
EXEL
#1799
Rank
A$16.56 B
Marketcap
A$61.53
Share price
-1.91%
Change (1 day)
12.44%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company